GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » Accumulated other comprehensive income (loss)

Vifor Pharma AG (XSWX:VIFN) Accumulated other comprehensive income (loss) : CHF0 Mil (As of Dec. 2021)


View and export this data going back to 2003. Start your Free Trial

What is Vifor Pharma AG Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Vifor Pharma AG's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2021 was CHF0 Mil.

Vifor Pharma AG Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Vifor Pharma AG's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Accumulated other comprehensive income (loss) Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vifor Pharma AG Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Vifor Pharma AG Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Vifor Pharma AG (XSWX:VIFN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XSWX:SFZN XSWX:PPGN XTER:MRK ZTS TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 VTRS SHSE:600196 NBIX NSE:DIVISLAB SZSE:000963 HKSE:03692 XTAE:TEVA SZSE:000661 SZSE:300142 SHSE:600085
Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Website
https://www.viforpharma.com
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (XSWX:VIFN) Headlines

No Headlines